2 Top Pharma Stocks to Buy in October
Over the past 10 years, pharmaceutical stocks have consistently outperformed major indices, with the Dow Jones US Pharmaceutical & Biotechnology Index up nearly 202% over that time period compared to the Dow Jones Industrial Average's 160% return. And even better than regular pharma stocks are sector players that are trading at dirt-cheap valuations, as they usually have the greatest potential for capital appreciation.
The ongoing coronavirus pandemic has caused a select few blue-chip pharma companies to fall way below their intrinsic values, even with all the bad news priced in. Let's take a look at which companies are in that space today and why they're among the stocks to buy in October.
Image source: Getty Images.
Source Fool.com
